[1] |
YOUNOSSI Z, STEPANOVA M, ONG JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates[J]. Clin Gastroenterol Hepatol, 2019, 17(4): 748-755. e3. DOI: 10.1016/j.cgh.2018.05.057.
|
[2] |
LANTHIER N. Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?[J]. World J Hepatol, 2015, 7(19): 2184-2188. DOI: 10.4254/wjh.v7.i19.2184.
|
[3] |
SHANG DF, LIU MH, ZHANG LH, et al. Study on the effect of cell pyrodeath on nonalcoholic steatohepatitis based on the theory of "Treating liver from lung"[J]. Chin J Basic Med Tradit Chin Med, 2022, 28(4): 582-585. DOI: 10.19945/j.cnki.issn.1006-3250.20211014.001.
尚东方, 刘鸣昊, 张丽慧, 等. 基于"从肺治肝"理论探讨干预细胞焦亡对非酒精性脂肪性肝炎的影响[J]. 中国中医基础医学杂志, 2022, 28(4): 582-585. DOI: 10.19945/j.cnki.issn.1006-3250.20211014.001.
|
[4] |
ZHANG LH, ZHANG JB, ZHAO WX. Effect of Huatan Qushi Huoxue prescription on the key proteins of the ADPN/PI3K/Akt signaling pathway in ratswith nonalcoholic steatohepatitis[J]. J Clin Hepatol, 2020, 36(4): 835-839. DOI: 10.3969/j.issn.1001-5256.2020.04.025.
张丽慧, 张剑波, 赵文霞. 化痰祛湿活血方对非酒精性脂肪性肝炎大鼠模型ADPN/PI3K/AKT通路关键蛋白的影响[J]. 临床肝胆病杂志, 2020, 36(4): 835-839. DOI: 10.3969/j.issn.1001-5256.2020.04.025.
|
[5] |
REID DT, MCDONALD B, KHALID T, et al. Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease[J]. Biochim Biophys Acta, 2016, 1862(7): 1337-1344. DOI: 10.1016/j.bbadis.2016.04.005.
|
[6] |
BOARU SG, BORKHAM-KAMPHORST E, TIHAA L, et al. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease[J]. J Inflamm (Lond), 2012, 9(1): 49. DOI: 10.1186/1476-9255-9-49.
|
[7] |
XU B, JIANG M, CHU Y, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice[J]. J Hepatol, 2018, 68(4): 773-782. DOI: 10.1016/j.jhep.2017.11.040.
|